Difficulty: Medium
Average Score: 63%
Practice
Moderate reduction of glomerular filtration rate 30ÔÇô59 ml/min/1.73 m2 is equal to chronic kidney disease stage
Correct answer
C
Rationale
In pediatric pharmacology, understanding the staging of chronic kidney disease (CKD) is crucial for managing patients with renal impairment. The correct answer to the question is option C) 3.
Rationale:
- Option A) 1 is incorrect because a glomerular filtration rate (GFR) of 30ÔÇô59 ml/min/1.73 m┬▓ corresponds to CKD stage 3, not stage 1. In stage 1, GFR is normal or high, but other signs of kidney damage are present.
- Option B) 2 is incorrect as a GFR of 30ÔÇô59 ml/min/1.73 m┬▓ falls under CKD stage 3, not stage 2. In stage 2, the GFR ranges from 60 to 89 ml/min/1.73 m┬▓.
- Option D) 4 is incorrect as stage 4 CKD is characterized by a GFR of 15ÔÇô29 ml/min/1.73 m┬▓, which is lower than the range specified in the question.
Educational Context:
Understanding the staging of CKD in pediatric patients is essential for healthcare providers to tailor appropriate pharmacological interventions and dosing adjustments. Recognizing the implications of reduced GFR levels helps in preventing drug accumulation and potential toxicity. By grasping the nuances of CKD staging, healthcare professionals can optimize therapy and improve outcomes for pediatric patients with renal disorders.
Rationale:
- Option A) 1 is incorrect because a glomerular filtration rate (GFR) of 30ÔÇô59 ml/min/1.73 m┬▓ corresponds to CKD stage 3, not stage 1. In stage 1, GFR is normal or high, but other signs of kidney damage are present.
- Option B) 2 is incorrect as a GFR of 30ÔÇô59 ml/min/1.73 m┬▓ falls under CKD stage 3, not stage 2. In stage 2, the GFR ranges from 60 to 89 ml/min/1.73 m┬▓.
- Option D) 4 is incorrect as stage 4 CKD is characterized by a GFR of 15ÔÇô29 ml/min/1.73 m┬▓, which is lower than the range specified in the question.
Educational Context:
Understanding the staging of CKD in pediatric patients is essential for healthcare providers to tailor appropriate pharmacological interventions and dosing adjustments. Recognizing the implications of reduced GFR levels helps in preventing drug accumulation and potential toxicity. By grasping the nuances of CKD staging, healthcare professionals can optimize therapy and improve outcomes for pediatric patients with renal disorders.